Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1785 SEK | +0.85% | -3.51% | -25.00% |
Sales 2022 | 4.74M 438K | Sales 2023 | 3M 277K | Capitalization | 8.18M 756K |
---|---|---|---|---|---|
Net income 2022 | -14M -1.29M | Net income 2023 | -12M -1.11M | EV / Sales 2022 | 0.7 x |
Net cash position 2022 | 3.19M 295K | Net cash position 2023 | 3.07M 284K | EV / Sales 2023 | 1.7 x |
P/E ratio 2022 |
-0.33
x | P/E ratio 2023 |
-1.04
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 7.12% |
1 day | +0.85% | ||
1 week | -3.51% | ||
Current month | -0.83% | ||
1 month | -24.68% | ||
3 months | -0.83% | ||
6 months | -48.56% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Joen Averstad
CEO | Chief Executive Officer | 40 | 11-12-31 |
Robert Thorén
DFI | Director of Finance/CFO | 47 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 50 | 09-12-31 | |
Founder | 52 | 09-12-31 | |
Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.1785 | +0.85% | 9,403 |
24-05-02 | 0.177 | -1.67% | 23,799 |
24-04-30 | 0.18 | -4.51% | 30,055 |
24-04-29 | 0.1885 | +1.89% | 105,081 |
24-04-26 | 0.185 | -4.64% | 70,615 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 03:39 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-25.00% | 4.77M | |
-1.89% | 12.5B | |
-9.59% | 7.67B | |
+21.82% | 5.36B | |
-1.31% | 5.26B | |
+0.02% | 4.57B | |
-50.89% | 3.15B | |
+6.42% | 2.59B | |
-10.02% | 2.06B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- BIOVIT Stock